Obesity, an independent risk factor for hepatocellular carcinoma (HCC) in NAFLD non-cirrhotic patients

1. Chen, C.L., Yang, H.I. & Yang, W.S., et al. (2008). Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology. 135(1), 111-121.10.1053/j.gastro.2008.03.07318505690Search in Google Scholar

2. Starley, B.Q., Calcagno, C.J. & Harrison, S.A., (2010). Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 51(5), 1820-32.10.1002/hep.2359420432259Search in Google Scholar

3. Caldwell, S.H., Crespo, D.M., Kang, H.S. & Al- Osaimi, A.M., (2004). Obesity and hepatocellular carcinoma. Gastroenterology. 127 (5 Suppl 1), S97-103.10.1053/j.gastro.2004.09.02115508109Search in Google Scholar

4. Ascha, M.S., Hanouneh, I.A., Lopez, R., Tamimi, T.A., Feldstein, A.F. & Zein, N.N., (2010). The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 51(6), 1972-8.10.1002/hep.2352720209604Search in Google Scholar

5. Inoue, M., Iwasaki, M., Otani, T., Sasazuki, S., Noda, M. & Tsugane, S. (2006). Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med. 166, 1871-7.10.1001/archinte.166.17.187117000944Search in Google Scholar

6. Inoue, M., Noda, M., Kurahashi, N., Iwasaki, M., Sasazuki, S., Iso, H. & Tsugane, S., (2009 Jun). Japan Public Health Center-based Prospective Study Group. Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan. Eur JCancer Prev. 18(3), 240-7.10.1097/CEJ.0b013e328324046019491612Search in Google Scholar

7. Oh, S.W., Yoon, Y.S. & Shin, S.A., (2005). Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J ClinOncol. 23, 4742-54.10.1200/JCO.2005.11.72616034050Search in Google Scholar

8. Gupta, K., Krishnaswamy, G., Karnad, A. & Peiris, A.N. (2002). Insulin: a novel factor in carcinogenesis. Am J Med Sci. 323, 140-5.10.1097/00000441-200203000-0000411908858Search in Google Scholar

9. El-Serag, H.B., Tran, T. & Everhart, J.E. (2004). Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 126, 460-8.10.1053/j.gastro.2003.10.06514762783Search in Google Scholar

10. Caldwell, S.H., Crespo, D.M., Kang, H.S. & Al- Osaimi, A.M. (2004). Obesity and hepatocellular carcinoma. Gastroenterology. 127, S97-103.10.1053/j.gastro.2004.09.021Search in Google Scholar

11. Marrero, J.A., Fontana, R.J., Fu, S., Conjeevaram, H.S., Su, G.L. & Lok, A.S. (2005). Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol. 42, 218-24.10.1016/j.jhep.2004.10.005Search in Google Scholar

12. Calle, E.E., Rodriguez, C., Walker-Thurmond, K. & Thun, M.J. (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 348(17), 1625-1638.10.1056/NEJMoa021423Search in Google Scholar

13. Møller, H., Mellemgaard, A., Lindvig, K. & Olsen, J.H. (1994). Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer. 30A(3), 344-350.10.1016/0959-8049(94)90254-2Search in Google Scholar

14. Oh, S.W., Yoon, Y.S. & Shin, S.A. (2005). Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol. 23(21), 4742-4754.10.1200/JCO.2005.11.72616034050Search in Google Scholar

15. Tilg, H. & Moschen, A.R. (2010). Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 52(5), 1836-1846.10.1002/hep.2400121038418Search in Google Scholar

16. Hashimoto, E. & Tokushige, K. (2012). Hepatocellular carcinoma in nonalcoholic steatohepatitis: Growing evidence of an epidemic? Hepatol Res. 42(1), 1-14.10.1111/j.1872-034X.2011.00872.xSearch in Google Scholar

17. Wang, Y., Ausman, L.M., Greenberg, A.S., Russell, R.M. & Wang, X.D. (2009). Nonalcoholic steatohepatitis induced by a highfat diet promotes diethylnitrosamine-initiated early hepatocarcinogenesis in rats. Int J Cancer. 124(3), 540-546.10.1002/ijc.23995267107919004024Search in Google Scholar

18. Park, E.J., Lee, J.H. & Yu, G.Y. et al (2010). Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 140(2), 197-208.10.1016/j.cell.2009.12.052283692220141834Search in Google Scholar

19. Roderburg, C. & Trautwein, C. (2010). Obesity and liver cancer: a key role for interleukin-6 and signal transducer and activator of transcription 3? Hepatology. 51(5), 1850-1852.10.1002/hep.2369320432261Search in Google Scholar

20. Sun, B. & Karin, M. (2011). Obesity, inflammation, and liver cancer. J Hepatol; In press.Search in Google Scholar

21. Bougoulia, M., Triantos, A. & Koliakos, G. (2006). Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women. Hormones (Athens). 5(4), 259-269.10.14310/horm.2002.1119017178701Search in Google Scholar

22. Gannagé-Yared, M.H., Khalife, S., Semaan, M., Fares, F., Jambart, S. & Halaby, G. (2006). Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur J Endocrinol. 155(1), 167-176.10.1530/eje.1.0217516793964Search in Google Scholar

23. Kamada, Y., Matsumoto, H. & Tamura, S. et al. (2007). Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model. J Hepatol. 47(4), 556-564.10.1016/j.jhep.2007.03.02017459514Search in Google Scholar

24. Bråkenhielm, E., Veitonmäki, N. & Cao, R. et al. (2004). Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. ProcNatlAcadSciUSA. 101(8), 2476-2481.10.1073/pnas.030867110035697514983034Search in Google Scholar

25. Tsochatzis, E.A., Papatheodoridis, G.V. & Archimandritis, A.J. (2009). Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy. Mediators Inflamm. 8(3), 16-27.10.1155/2009/831670269430919753129Search in Google Scholar

26. Ikejima, K., Honda, H. & Yoshikawa, M. et al. (2001). Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatology. 34(2), 288-297.10.1053/jhep.2001.2651811481614Search in Google Scholar

27. Marra, F. (2002). Leptin and liver fibrosis: a matter of fat. Gastroenterology. 122, 1399-1410.10.1053/gast.2002.3336911984539Search in Google Scholar

28. Ish-Shalom, D., Christoffersen, C.T. & Vorwerk, P. et al. (1997). Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor. Diabetologia. 40 (Suppl 2), S25-S31.10.1007/s0012500513939248698Search in Google Scholar

29. Buzzelli, G., Dattolo, P., Pinzani, M., Brocchi, A., Romano, S. & Gentilini, P. (1993). Circulating growth hormone and insulin-like growth factor-I in nonalcoholic liver cirrhosis with or without superimposed hepatocarcinoma: evidence of an altered circadian rhythm. Am J Gastroenterol. 88(10), 1744-1748.Search in Google Scholar

30. Price, J.A., Kovach, S.J. & Johnson, T. et al. (2002). Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma. Hepatology. 36(5), 1089-1097.10.1053/jhep.2002.3615812395318Search in Google Scholar

31. Tanaka, S., Mohr, L., Schmidt, E.V., Sugimachi, K. & Wands, J.R. (1997). Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes. Hepatology. 26(3), 598-604.10.1002/hep.5102603109303488Search in Google Scholar

32. Aleem, E., Nehrbass, D., Klimek, F., Mayer, D. & Bannasch, P. (2011). Upregulation of the insulin receptor and type I insulin-like growth factor receptor are early events in hepatocarcinogenesis. ToxicolPathol. 39(3), 524-543.10.1177/019262331039690521411721Search in Google Scholar

33. Longato, L., de la Monte, S. & Kuzushita, N. et al. (2009). Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver. Hepatology. 49(6), 1935-1943.10.1002/hep.22856275428419475691Search in Google Scholar

34. Longato, L., de la Monte, S., Califano, S. & Wands, J.R. (2008). Synergistic premalignant effects of chronic ethanol exposure and insulin receptor substrate-1 overexpression in liver. Hepatol Res. 38(9), 940-953.10.1111/j.1872-034X.2008.00336.x18336544Search in Google Scholar

35. Adams, L.A. & Feldstein, A.E. (2010). Nonalcoholic steatohepatitis: risk factors and diagnosis. Expert Rev GastroenterolHepatol. 4, 623-35.10.1586/egh.10.5620932147Search in Google Scholar

36. Cadranel, J.F., Rufat, P. & Degos, F. (2000). Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology; 32, 477-81.10.1053/jhep.2000.1660210960438Search in Google Scholar

37. Festi, D., Schiumerini, R., Marzi, L., Di Biase, A. R., Mandolesi, D., Montrone, L., Scaioli, E., Bonato, G., Marchesini-Reggiani, G. & Colecchia, A. (2013). Review Article: The Diagnosis of Non-alcoholic Fatty Liver Disease Availability and Accuracy of Non-invasive Methods. Aliment PharmacolTher. 37(4), 392-400.10.1111/apt.1218623278163Search in Google Scholar

38. Sun, B. & Karin, M. (2012 Mar). Obesity, inflammation, and liver cancer. J Hepatol. 56(3), 704-13. DOI: 10.1016/j.jhep.2011.09.020.10.1016/j.jhep.2011.09.020388966022120206Search in Google Scholar